Aligos Therapeutics (ALGS) Price to Book (2020 - 2026)

Aligos Therapeutics (ALGS) has reported Price to Book for 7 consecutive years, with 1.89 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 157.65% year-over-year to 1.89; the trailing twelve-month figure through Jun 2026 stood at 1.89 (up 157.65% YoY), and the FY2025 full-year result was 1.72, up 119.97% from the prior year.
• Price to Book slipped to 1.89 in Q2 2026 per ALGS's latest filing, from 2.43 in the prior quarter.
• Across five years, Price to Book topped out at 63.98 in Q1 2024 and bottomed at 8.61 in Q4 2024.
• Historically, Price to Book has averaged 10.12 across 5 years, with a median of 9.55 in 2022.
• The widest YoY moves for Price to Book: up 477.93% in 2024, down 174.36% in 2024.
• Over 5 years, Price to Book stood at 9.84 in 2022, then increased by 17.68% to 11.58 in 2023, then tumbled by 174.36% to 8.61 in 2024, then soared by 119.97% to 1.72 in 2025, then rose by 9.71% to 1.89 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 1.89, 2.43, and 1.72 for Q2 2026, Q1 2026, and Q4 2025 respectively.